In the proximal colon cancer network, KRAS mutation tended to be mutually exclusive only with BRAF mutation, indicating that the observed negative correlations of KRAS mutation with methylation-related markers and other biomarkers might be confounded by MSI-high in our earlier analysis. This evidence concerns the gene KRAS and colonic neoplasm.